Kas József, Kocsis Ákos, Kiss Dorottya, Simon Veronika, Komoly Sámuel, Rózsa Csilla, Svastics Egon
Mellkassebészet, Budai MÁV Kórház Budapest.
Mellkassebészet, Országos Onkológiai Intézet Budapest (Jelenlegi munkahely/Present working place).
Magy Seb. 2019 Sep;72(3):83-97. doi: 10.1556/1046.72.2019.3.1.
Thymectomy became an important part of the treatment of myasthenia gravis, since Alfred Blalock reported about his first surgery 80 years ago. Despite of several different surgical techniques already accepted abroad, sternal approach was the almost exclusive exposure for thymectomy in Hungary till 2006. In this publication, we analyze the direct surgical consequences and complications of this method. At the Surgical Department of Budai MÁV Hospital, 1002 transsternal thymectomies were performed during 34 years on patients suffering from myasthenia gravis. Surgeries were performed for neurological indications, following careful medical investigations, involving specialists in neurology and internal medicine. In cases associated with thymoma, surgery was indicated for two reasons: removal of the thymus and the tumor at the same time. Neurological indications, patient preparation, perioperative treatment and surgical technique have considerably changed during these 34 years. We interpret the results according to the two eras based on the most frequently applied surgical techniques (simple and extended thymectomy); we publish the data separately of the patients with thymoma and those who underwent repeated surgery, focusing basically on breath-related complications. The patients' age was 32 years on the average (8-73 years). Women/men ratio: 3.5:1. Myasthenia gravis was associated with thymoma in 12.7% of the patients. Repeated thymectomy was necessary in case of 11 patients; further two patients required repeated sternotomy after cardiac surgery. Respiratory failure occurred in 21,3% out of 525 myasthenic patients operated in the first 19-year-old era, emergency re-intubation and tracheostomy happened in 12,8% and in 11,2% as well. In the second 15-year-old period postoperative respiratory failure occurred in 12,7% with emergency re-intubation in 7,1% and tracheostomy only in 1,2% out of 338 myasthenic patients. Respiratory failure occurred in 19.1% out of 126 patients operated for thymoma; re-intubation was necessary in 12.8% of the cases and tracheostomy was performed in 20.6% of the patients. Respiratory failure occurred in 13 patients, who underwent repeated surgery (46.1%); the ratio of re-intubation was 15.4% and that of tracheostomies 46.1%. Serious surgical complications were infrequent also in the entire group of patients: 2 patients required repeated surgery due to sternal bleeding; one more patient underwent repeated surgery due to rupture of the drainage tube, 4 cases of mediastinitis in the first group, two cases of heart injury and one case of sternal disruption occurred in the second period. The overall mortality was 1.4%: 1.3% in the first period, 0.3% in the second period, 4% in the thymoma group and 7.7% after repeated surgeries. In a historical overview, the ratio of serious respiratory and airway complications and the mortality after transsternal thymectomies has considerably decreased, but the postoperative respiratory failure and the surgical risk of transsecting the sternum still pose a real risk.
自80年前阿尔弗雷德·布莱洛克报告其首例胸腺切除术以来,胸腺切除术已成为重症肌无力治疗的重要组成部分。尽管国外已有几种不同的手术技术被广泛接受,但直到2006年,胸骨入路仍是匈牙利胸腺切除术几乎唯一的手术方式。在本出版物中,我们分析了该方法的直接手术后果及并发症。在布达伊马夫医院外科,34年间对1002例重症肌无力患者实施了经胸骨胸腺切除术。手术是在经过神经科和内科专家仔细的医学检查后,根据神经学指征进行的。对于合并胸腺瘤的病例,手术有两个指征:同时切除胸腺和肿瘤。在这34年中,神经学指征、患者准备、围手术期治疗和手术技术都有了很大变化。我们根据基于最常用手术技术(单纯胸腺切除术和扩大胸腺切除术)的两个时代来解读结果;我们分别公布胸腺瘤患者和接受再次手术患者的数据,主要关注与呼吸相关的并发症。患者平均年龄为32岁(8至73岁)。女性/男性比例为3.5:1。12.7%的患者重症肌无力合并胸腺瘤。11例患者需要再次进行胸腺切除术;另有2例患者在心脏手术后需要再次开胸。在最初19年的时间段内,525例重症肌无力患者中有21.3%发生呼吸衰竭,紧急再次插管和气管切开分别占12.8%和11.2%。在第二个15年的时间段内,338例重症肌无力患者中有12.7%发生术后呼吸衰竭,紧急再次插管占7.1%,仅气管切开占1.2%。126例胸腺瘤手术患者中有19.1%发生呼吸衰竭;12.8%的病例需要再次插管,20.6%的患者进行了气管切开。13例接受再次手术的患者中有13例发生呼吸衰竭(46.1%);再次插管的比例为15.4%,气管切开的比例为46.1%。严重手术并发症在整个患者群体中也不常见:2例患者因胸骨出血需要再次手术;另有1例患者因引流管破裂接受再次手术,第一组有4例纵隔炎,第二阶段有2例心脏损伤和1例胸骨断裂。总死亡率为1.4%:第一阶段为1.3%,第二阶段为0.3%,胸腺瘤组为4%,再次手术后为7.7%。从历史回顾来看,经胸骨胸腺切除术后严重呼吸和气道并发症的比例以及死亡率已大幅下降,但术后呼吸衰竭和胸骨切开的手术风险仍然是实际存在的风险。